What should personalized, precision treatment of cancer look like in the future?
We know that people are different, their tumors are different, and they respond differently to different therapies. Medical teams of the future might be able to create a ?“virtual twin” of a person and their tumor. Then, by tapping supercomputers, physician-led teams could simulate how tumor cells behave to test millions (or billions) of possible treatment combinations. Ultimately, the best combinations might offer clues towards a personalized, effective treatment plan.
Sound like wishful thinking? The first steps towards this vision have been undertaken by a multi-institution research collaboration that includes Jonathan Ozik and Nicholson Collier, computational scientists at the U.S. Department of Energy’s Argonne National Laboratory.
The research team, which includes collaborators at Indiana University and the University of Vermont Medical Center, brought the power of high-performance computing to the thorny challenge of improving cancer immunotherapy. The team tapped twin supercomputers at Argonne and the University of Chicago, finding that high-performance computing can yield clues in fighting cancer, as discussed in a June 7 article published in Molecular Systems Design and Engineering.
“With this new approach, researchers can use agent-based modeling in more scientifically robust ways.” — Nicholson Collier, computational scientist at Argonne and the University of Chicago
Standing up to cancer
Cancer immunotherapy is a promising treatment that realigns your immune system to reduce or eliminate cancer cells. The therapy, however, helps only 10 to 20 percent of patients — partly because the way in which cancer cells and immune cells mingle is complex and poorly understood. Proven rules are scarce.
To begin uncovering the rules of immunotherapy, the team turned to a set of three tools:
- Agent-based modeling, which predicted the behavior of individual ?“agents” – cancer and immune cells, in this case
- Argonne’s award-winning workflow technology to take full advantage of the supercomputers
- A guiding framework to explore models and dynamically direct and track results
The trio operate in a hierarchy. The framework, developed by Ozik, Collier, Argonne colleagues, and Gary An, a surgeon and professor at the University of Vermont Medical Center, is called Extreme-scale Model Exploration with Swift (EMEWS). It oversees the agent-based model and the workflow system, the Swift/T parallel scripting language, developed at Argonne and the University of Chicago.
What is unique about this combination of tools? ?“We are helping more people in a variety of computational science fields to do large-scale experimentation with their models,” said Ozik, who — like Collier — holds a joint appointment at the University of Chicago. ?“Building a model is fun. But without supercomputers, it is difficult to really understand the full potential of how models can behave.”
The Latest on: Personalized medicine
via Google News
The Latest on: Personalized medicine
- Atossa Therapeutics President and CEO Dr. Steven C. Quay to Speak at Precision Medicine World ...on January 25, 2021 at 6:50 am
Dr. Anthony S. Fauci will be the spotlight speaker of the event. Dr. Fauci is the Director of the U.S. National Institute of Allergy and Infectious Diseases and Chief Medical Advisor to the President.
- PSMA PET Imaging in Prostate Cancer - A Step Towards Personalized Medicine An Interdisciplinary Educational Serieson January 22, 2021 at 10:48 am
Molecular imaging with PSMA PET continues to pave the way for personalized medicine in prostate cancer. In this interdisciplinary education series, A Step Towards Personalized Medicine: PSMA PET ...
- Personalized Medicine Market Overview And Geographical Forecast Till 2026 | Fortune Business Insightson January 19, 2021 at 5:31 pm
Global " Personalized Medicine Market Size" 2020 report includes the market strategy, market orientation, expertise ...
- The body's own signaling system provides the key to new diagnostic tools and personalized medicineon January 15, 2021 at 6:26 am
Several studies have demonstrated that tiny biological particles called exosomes may carry important information about diseases. We are currently searching for these tiny particles in cooperation with ...
- Personalized cancer treatments no longer a dream with new medical techon January 14, 2021 at 12:19 am
ADVA X3 is a device that can create life-saving drugs automatically and customized for each individual patient.
- US FDA works to provide clarity on new drugs in an age of personalized medicineon January 13, 2021 at 6:30 pm
US FDA works to provide clarity on new drugs in an age of personalized medicine: Nandita Vijay, Bengaluru Thursday, January 14, 2021, 08:00 Hrs [IST] The US FDA now sees the need ...
- 2021 Prostate Cancer - Oliver Sartor (Presentation: A Step Towards Personalized Medicine: PET-PSMA Imaging in Prostate Cancer) - 1981on January 13, 2021 at 12:52 am
Welcome everyone to implementation for "A Step Towards Personalized Medicine, PET-PSMA Imaging in Prostate Cancer". This is one of a multi-part series. I'm Neal Shore, the Medical Director of Carolina ...
- ANANDA Scientific and NYU Grossman School of Medicine Announce Clinical Trial Utilizing Liquid Structure™ Cannabidiol (CBD) for Treatment of Post-Traumatic Stress Disorder (PTSD)on January 12, 2021 at 8:45 am
ANANDA Scientific Inc., a biotech pharma company, and NYU Grossman School of Medicine today announced a new clinical trial evaluating the efficacy of ...
- Personalized Medicine Market 2020 Key Dynamics, Recent and Future Demand, Trend, Analysis upto 2027on January 10, 2021 at 6:47 pm
Global " Personalized Medicine Market" 2020 report includes the market strategy, market orientation, expertise opinion ...
- Will Personalized Medicine Help in 'Transforming' the Business of Healthcare?on January 3, 2021 at 4:01 pm
I mentioned at the beginning of this perspective that I did not find the present direction/definition for personalized medicine optimal. I will now present my personal preference of the direction ...
via Bing News